Trademarkia Logo

Canada

C$
Trademark Search in Canada
rigel & Design

View On IC.GC.CA

rigel & Design
REGISTERED

on 8 Sept 2021

Last Applicant/ Owned by

RIGEL PHARMACEUTICALS, INC.

1180 Veterans BoulevardSan Francisco, CA 94080

US

Serial Number

1917847 filed on 31st Aug 2018

Registration Number

TMA1108868 registered on 8th Sept 2021

Registration expiry Date

8th Sept 2031

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

rigel & Design

Trademark usage description

pharmaceutical preparations for the treatment of cancer, auto-immune diseases, inflammatory diseases and disorders, namely, inflammatory bowel disease Read More

Vienna Information

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer, auto-immune diseases, inflammatory diseases and disorders, namely, inflammatory bowel disease, coeliac disease, ulcerative colitis, inflammatory connective tissue diseases, inflammatory pelvic diseases, hematological conditions, diseases and disorders, namely, thrombocytopenia, leukemia, autoimmune hemolytic anemia, blood disorders, diseases and conditions, immunologic deficiency syndromes, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, anemia, cystic fibrosis; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, auto-immune diseases, immunologic deficiency syndromes, immune thrombocytopenia, vasculitis, inflammatory bowel disease, Systemic lupus erythematosus; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel disease, coeliac disease, ulcerative colitis, inflammatory connective tissue diseases, inflammatory pelvic diseases; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of blood disorders, diseases and conditions

Classification kind code

11

Class [016]
Printed publications, namely, reports, manuals, brochures, newsletters and leaflets in the field of medicine, pharmaceuticals and medical and pharmaceutical research

Classification kind code

11

Class [042]
Research and development of technologies and scientific data in the field of new drug development for others; Medical and scientific research in the field inflammatory disease and disorders, immune system disease and disorders, metabolic disease and disorders, dermatological and hematological disease and disorders, cancer and rare diseases

Classification kind code

11

Class [044]
Providing information for medical professionals, pharmacies, and consumers regarding therapeutic properties of pharmaceuticals, the treatment of diseases and medical conditions, and information about the administration and dosing of pharmaceuticals, via a website; providing information related to inflammatory disease and disorders, immune system disease and disorders, metabolic disease and disorders, dermatological and hematological disease and disorders, cancer and rare diseases, via a website

Classification kind code

11

Mark Details

Serial Number

1917847

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 25th Aug 2021		Registration Pending
Submitted for opposition 42
on 2th Jun 2021		Advertised
Submitted for opposition 27
on 4th May 2021		Approval Notice Sent
Submitted for opposition 26
on 4th May 2021		Approved
Submitted for opposition 22
on 30th Sept 2020		Search Recorded
Submitted for opposition 20
on 30th Sept 2020		Examiner's First Report
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 31
on 6th Sept 2018		Formalized
Submitted for opposition 1
on 4th Sept 2018		Created
Submitted for opposition 30
on 31st Aug 2018		Filed